Arrowhead's ARO-MUC5AC trial marked terminated for business reasons; results posted to registrySep 14Trial updateARO-MUC5ACArrowhead Pharmaceuticals
Arrowhead posts Phase 1/2a results for inhaled ARO-MMP7 in IPF trialAug 5Trial updateArrowhead Pharmaceuticals
Arrowhead reports fiscal Q3 2026 results with plozasiran Phase 3 data and Madrigal dealAug 4Quarterly updateArrowhead Pharmaceuticalsplozasiran
Sign in